Early treatment of acute or recently acquired hepatitis C - an important tool on the path to HCV elimination!

1Dept. of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Germany 2German Liver Foundation, Germany 3German Center for Infection Research (DZIF); Partner Site Hannover-Braunschweig, Germany 4Center for Individualized Infection Medicine (CiiM), Hannover, Germany To be included: Pol et al. Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective study. Correspondence Markus Cornberg, Dept. of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Germany. Email: [email protected] Correspondence Heiner Wedemeyer, Dept. of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Germany. Email: [email protected]